Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.11, Iss.2, 2007-02, pp. : 145-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biological activity of plant extracts: novel analgesic drugs

By Calixto João B Scheidt Cristiano Otuki Michel Santos Adair RS

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 2, 2001-10 ,pp. : 261-279

Informa Healthcare

Access to resources Recommend Favorite

The Brain Galanin Receptors: Targets for Novel Antidepressant Drugs

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 3, 2007-06 ,pp. : 183-192

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin-Dopamine Interaction as a Focus of Novel Antidepressant Drugs

Current Drug Targets, Vol. 7, Iss. 2, 2006-02 ,pp. : 177-185

Bentham Science Publishers

Access to resources Recommend Favorite

Increasing Hippocampal Neurogenesis: A Novel Mechanism for Antidepressant Drugs

Current Pharmaceutical Design, Vol. 11, Iss. 2, 2005-01 ,pp. : 145-155

Bentham Science Publishers

Access to resources Recommend Favorite

Natural and Synthetic Inhibitors of Caspases: Targets for Novel Drugs

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 4, 2004-08 ,pp. : 333-340

Bentham Science Publishers

Access to resources Recommend Favorite